Latest Drug Approvals news
FDA Approves Inluriyo for Advanced Breast Cancer
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Opzelura for Atopic Dermatitis in Children
posted September 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Grants Accelerated Approval for First Treatment for Barth Syndrome
posted September 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Subcutaneous Tremfya Induction Treatment for Ulcerative Colitis
posted September 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
